Pfizer COVID-19 Vaccine Protects for 6 Months or More: Study Pfizer COVID-19 Vaccine Protects for 6 Months or More: Study
The ongoing phase 3 Pfizer/BioNTech trial that led to emergency use authorization has provided updated information on duration of protection and effectiveness against variants.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news
More News: COVID-19 | Drugs & Pharmacology | Emergency Medicine | Infectious Diseases | Pfizer | Study | Vaccines